India's First mRNA COVID Vaccine

India plans to start human trials on its first home-grown COVID vaccine based on Messenger RNA (mRNA) technology, said experts.

In August, the Drug Controller General of India had approved the Phase 2 and 3 clinical trials.

COVID-19 Vaccine: Myths and Facts
Debunking several misconceptions or myths that have surfaced regarding covid vaccination is important and focus on the facts related to COVID-19 vaccines.

‘Pune-based Gennova Biopharmaceuticals is making India's first mRNA COVID-19 vaccine known as HGC019, in collaboration with US-based HDT Bio Corp.’

"The Vaccine Subject Expert Committee (SEC) reviewed the data, and found HGCO19 to be safe, tolerable, and immunogenic in the participants of the study," the company had said in a statement.

The company will start testing the vaccine on humans for efficacy and immunogenicity next month. The mRNA vaccine is also reportedly effective against the new Omicron variant.

The mRNA vaccines carry the molecular information to make the protein in the host using the synthetic RNA of the virus. The host body produces the viral protein recognized by the immune system, thereby enabling the body to fight against the disease.

Test your Knowledge on Coronavirus (COVID-19)
Coronavirus is a large positive-strand RNA virus that is surrounded by a protein envelope. The virus obtains its name from the S protein spikes on its surface, which resemble a crown. The overall pattern of increasing coronavirus cases is shown to spike up with the “second wave” of COVID-19.

With spiking effects of the second wave of coronavirus, the best way to keep it at bay is to follow COVID-appropriate safety practices like wearing a mask, regularly cleaning your hands, and coughing into a bent elbow or tissue along with physical distancing (6 feet about 2 arm's length), that may help evade the severity of COVID-19 infection.

mRNA vaccines are considered safe as mRNA is non-infectious, non-integrating in nature, and degraded by standard cellular mechanisms. They are highly efficacious because of their inherent capability of being translated into proteins in the cell.

First Dose of COVID-19 Vaccines May Improve Mental Health
Short-term study shows that COVID-19 vaccination aids in boosting mental health. The stress relapse was reduced even drastically among those who have completed both doses of vaccines.

These vaccines also represent a promising alternative to conventional vaccine approaches because of their high potency, capacity for rapid development, and potential for low-cost manufacture and safe administration.

Researchers have been studying and working with mRNA vaccines for decades. It can be developed in a laboratory using readily available materials, meaning the manufacturing can be faster.

Breast Milk of Mothers Who Received COVID-19 Vaccine Contains Antibodies That Fight Illness
The breast milk of mothers who have received COVID-19 vaccine contains a significant supply of antibodies that may help protect nursing infants from the illness.

mRNA vaccines have elicited potent immunity against infectious disease targets in animal models of influenza virus, Zika virus, rabies virus, and others, especially in recent years.

It has also been employed in numerous cancer clinical trials, with some promising results showing antigen-specific T cell responses and prolonged disease-free survival in some cases.

Future mRNA vaccine technology may allow for one vaccine to provide protection against multiple diseases, thus decreasing the number of shots needed for protection against common vaccine-preventable diseases.

Source-IANS